Search Results - "Calderon, Moises"

The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment by Rodríguez del Río, Pablo, Vidal, Carmen, Just, Jocelyne, Tabar, Ana I., Sanchez‐Machin, Inmaculada, Eberle, Peter, Borja, Jesus, Bubel, Petra, Pfaar, Oliver, Demoly, Pascal, Calderón, Moises A.

“…Background Safety data on ‘real‐life’ allergen immunotherapy (AIT) in children and adolescents is usually extrapolated from studies in adults. Methods Patients…”
Get full text

An evidence-based analysis of house dust mite allergen immunotherapy: A call for more rigorous clinical studies by Calderon, Moises A., MD, PhD, Casale, Thomas B., MD, Nelson, Harold S., MD, Demoly, Pascal, MD, PhD

“…Background According to meta-analyses and reviews, subcutaneous allergen immunotherapy (SCIT) and sublingual allergen immunotherapy (SLIT) are beneficial in…”
Get full text

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report by Burks, A. Wesley, MD, Calderon, Moises A., MD, PhD, Casale, Thomas, MD, Cox, Linda, MD, Demoly, Pascal, MD, PhD, Jutel, Marek, MD, Nelson, Harold, MD, Akdis, Cezmi A., MD

“…Allergy immunotherapy (AIT) is an effective treatment for allergic asthma and rhinitis, as well as venom-induced anaphylaxis. In addition to reducing symptoms,…”
Get full text

Integrating the evidence in allergen immunotherapy: Why real-world data should be important for the practicing clinician? by Calderon, Moises A, Demoly, Pascal

“…Data obtained from controlled clinical trials are the gold standard for evaluation of allergen immunotherapy (AIT) efficacy and safety. Less prone to biases…”
Get more information

House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies by Calderón, Moisés A., MD, PhD, Kleine-Tebbe, Jörg, MD, Linneberg, Allan, MD, PhD, De Blay, Frédéric, MD, PhD, Hernandez Fernandez de Rojas, Dolores, MD, PhD, Virchow, Johann Christian, MD, FRCP, FCCP, Demoly, Pascal, MD, PhD

“…Although house dust mite (HDM) allergy is a major cause of respiratory allergic disease, specific diagnosis and effective treatment both present unresolved…”
Get full text

Sublingual immunotherapy for allergic rhinitis by Radulovic, Suzana, Calderon, Moises A, Wilson, Duncan, Durham, Stephen

“…This is an update of a Cochrane Review first published in The Cochrane Library in Issue 2, 2003.Allergic rhinitis is a common condition which can significantly…”
Get more information

Basophil expression of diamine oxidase: A novel biomarker of allergen immunotherapy response by Shamji, Mohamed H., PhD, Layhadi, Janice A., MSc, Scadding, Guy W., MRCP, Cheung, Delica K.M., MSc, Calderon, Moises A., MD, PhD, Turka, Laurence A., MD, Phippard, Deborah, PhD, Durham, Stephen R., MD, FRCP

“…Background Immunotherapy inhibits basophil histamine release, but the assay is cumbersome, and no one has studied the effects of immunotherapy withdrawal…”
Get full text

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity by Francis, James N., PhD, James, Louisa K., PhD, Paraskevopoulos, Giannis, MD, Wong, Cheukyee, BSc, Calderon, Moises A., MD, PhD, Durham, Stephen R., MD, Till, Stephen J., MD, PhD

“…Background Grass pollen immunotherapy is an effective treatment for seasonal allergic rhinitis that provides the opportunity to study the induction and…”
Get full text

International consensus on allergy immunotherapy by Jutel, Marek, MD, Agache, Ioana, MD, Bonini, Sergio, MD, Burks, A. Wesley, MD, Calderon, Moises, MD, Canonica, Walter, MD, Cox, Linda, MD, Demoly, Pascal, MD, Frew, Antony J., MD, O'Hehir, Robin, MD, Kleine-Tebbe, Jörg, MD, Muraro, Antonella, MD, Lack, Gideon, MD, Larenas, Désirée, MD, Levin, Michael, MD, Nelson, Harald, MD, Pawankar, Ruby, MD, Pfaar, Oliver, MD, van Ree, Ronald, PhD, Sampson, Hugh, MD, Santos, Alexandra F., MD, PhD, Du Toit, George, MD, Werfel, Thomas, MD, Gerth van Wijk, Roy, MD, Zhang, Luo, MD, Akdis, Cezmi A., MD

“…Allergen immunotherapy (AIT) has been used to treat allergic disease since the early 1900s. Despite numerous clinical trials and meta-analyses proving AIT…”
Get full text

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial by Scadding, Guy W, Calderon, Moises A, Shamji, Mohamed H, Eifan, Aarif O, Penagos, Martin, Dumitru, Florentina, Sever, Michelle L, Bahnson, Henry T, Lawson, Kaitie, Harris, Kristina M, Plough, Audrey G, Panza, Joy Laurienzo, Qin, Tielin, Lim, Noha, Tchao, Nadia K, Togias, Alkis, Durham, Stephen R

“…IMPORTANCE: Sublingual immunotherapy and subcutaneous immunotherapy are effective in seasonal allergic rhinitis. Three years of continuous treatment with…”
Get full text

Real‐life report of allergen immunotherapy management during the COVID‐19 outbreak in France and Spain by Rodriguez del Rio, Pablo, Caimmi, Davide, Rico, Pilar, Vidal, Carmen, Carmen, Moreno, Pintoiu, Ileana M., Beitia Mazuecos, Jose M., Gonzalez de Olano, David, Cuesta Alvaro, Pedro, Demoly, Pascal, Calderon, Moises A.

Get full text

Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti–IL-4: A randomized controlled trial by Chaker, Adam M., MD, Shamji, Mohamed H., PhD, Dumitru, Florentina A., MD, PhD, Calderon, Moises A., MD, PhD, Scadding, Guy W., MRCP, Makatsori, Melina, MD, Jones, Ieuan, BA, He, Qiuling A., PhD, Subramanian, Kulandayan K., PhD, Arm, Jonathan P., MD, Durham, Stephen R., MD, FRCP, Schmidt-Weber, Carsten B., PhD

“…Background Allergen immunotherapy is currently the only disease-modifying treatment available for allergic rhinitis and allergic asthma. Objectives We sought…”
Get full text

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics by Jutel, Marek, MD, Agache, Ioana, MD, Bonini, Sergio, MD, Burks, A. Wesley, MD, Calderon, Moises, MD, Canonica, Walter, MD, Cox, Linda, MD, Demoly, Pascal, MD, Frew, Antony J., MD, FRCP, O'Hehir, Robyn, FRACP, PhD, Kleine-Tebbe, Jörg, MD, Muraro, Antonella, MD, PhD, Lack, Gideon, MD, Larenas, Désirée, MD, Levin, Michael, MD, Martin, Bryan L., MD, Nelson, Harald, MD, Pawankar, Ruby, MD, Pfaar, Oliver, MD, van Ree, Ronald, PhD, Sampson, Hugh, MD, Sublett, James L., MD, Sugita, Kazunari, MD, Du Toit, George, MD, Werfel, Thomas, MD, Gerth van Wijk, Roy, MD, Zhang, Luo, MD, Akdis, Mübeccel, MD, Akdis, Cezmi A., MD

“…This article continues the comprehensive international consensus (ICON) statement on allergen immunotherapy (AIT). The initial article also recently appeared…”
Get full text

Network Meta-analysis Shows Commercialized Subcutaneous and Sublingual Grass Products Have Comparable Efficacy by Nelson, Harold, MD, Cartier, Shannon, MSc, Allen-Ramey, Felicia, PhD, Lawton, Simon, MD, Calderon, Moises A., MD

“…Background Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) have been shown to effectively treat grass pollen allergies, although direct…”
Get full text

Real-life clinical practice and management of polysensitized patients with respiratory allergies: a large, global survey of clinicians prescribing allergen immunotherapy by Wahn, Ulrich, Calderon, Moises A, Demoly, Pascal

“…The allermix survey was conducted to gain insights into the most frequently diagnosed allergies worldwide, the use of allergen immunotherapy (AIT) in clinical…”
Get more information

Specific allergen immunotherapy for the treatment of atopic eczema by Tam, Herman, Calderon, Moises A, Manikam, Logan, Nankervis, Helen, García Núñez, Ignacio, Williams, Hywel C, Durham, Stephen, Boyle, Robert J

“…Specific allergen immunotherapy (SIT) is a treatment that may improve disease severity in people with atopic eczema (AE) by inducing immune tolerance to the…”
Get more information

Could Allergen Immunotherapy be a Therapeutic Intervention in Eosinophilic Oesophagitis? by Calderon, Moises A., MD, PhD

“…The predominant allergens were grasses group 1 and, in particular, nCyn d 1 (Cynodon dactylon) or Bermuda grass pollen, followed by lipid transfer proteins…”
Get full text

Allergen injection immunotherapy for seasonal allergic rhinitis by Calderon, M A, Alves, B, Jacobson, M, Hurwitz, B, Sheikh, A, Durham, S

“…Allergic rhinitis is the most common of the allergic diseases. Despite improved understanding of the pathophysiology of allergic rhinitis and advances in its…”
Get more information

Sublingual grass and ragweed immunotherapy: Clinical considerations—a PRACTALL consensus report by Li, James T., MD, PhD, Bernstein, David I., MD, Calderon, Moises A., MD, PhD, Casale, Thomas B., MD, Cox, Linda, MD, Passalacqua, Giovanni, MD, Pfaar, Oliver, MD, Papadopoulos, Nikolaos G., MD

“…Sublingual allergen immunotherapy provides a new option for patients with allergic rhinitis in the United States. The efficacy of these sublingual…”
Get full text

New Allergic and Hypersensitivity Conditions Section in the International Classification of Diseases-11 by Tanno, Luciana K, Calderon, Moises A, Demoly, Pascal

“…Allergy and hypersensitivity, originally perceived as rare and secondary disorders, are one of the fastest growing conditions worldwide, but not adequately…”
Get full text